Lack of association of mannose binding lectin variant alleles with systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 65, Issue 2, 2006, Pages 278-279

  Momot, T ^a   Ahmadi Simab, K ^a   Gause, A ^a   Gross, W L ^a   Gromnica Ihle, E ^a   Peter, H H ^a   Manger, K ^a   Zeidler, H ^a   Schmidt, R E ^a   Witte, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN;

ADULT; ALLELE; ARTERY THROMBOSIS; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DNA DETERMINATION; FEMALE; GENETIC ASSOCIATION; HEART INFARCTION; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FAMILY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ALLELES; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; RISK FACTORS;

EID: 31144464810     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.042929     Document Type: Article

References (10)

1. Super M, Gillies SD, Foley S, Sastry K, Schweinle JE, Silverman VJ, et al. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet 1992;2:50-5.
2. Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW, et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991;337:1569-70.
3. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 2003;40:73-84.
4. Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2001;2:442-50.
5. Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 2004;351:260-7.
6. Momot T, Koch S, Hunzelmann N, Krieg T, Ulbricht K, Schmidt RE, et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 2004;50:1561-5.
7. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
8. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
9. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998;161:3169-75.
10. Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 2002;61:1065-70.